Churchill Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,851
Closed -$1.48M 156
2024
Q3
$1.48M Sell
2,851
-105
-4% -$56.1K 0.02% 129
2024
Q2
$1.6M Sell
2,956
-230
-7% -$122K 0.02% 126
2024
Q1
$1.65M Sell
3,186
-306
-9% -$152K 0.02% 128
2023
Q4
$1.65M Buy
+3,492
New +$1.61M 0.03% 117
2023
Q3
Sell
-25,690
Closed -$11.4M 148
2023
Q2
$11.4M Sell
25,690
-219
-0.8% -$101K 0.19% 56
2023
Q1
$11.9M Sell
25,909
-188
-0.7% -$89.5K 0.24% 48
2022
Q4
$13.4M Buy
26,097
+127
+0.5% +$64.5K 0.32% 37
2022
Q3
$11.8M Sell
25,970
-571
-2% -$273K 0.32% 40
2022
Q2
$12.8M Buy
26,541
+377
+1% +$187K 0.32% 36
2022
Q1
$12.9M Buy
+26,164
New +$12M 0.23% 47
2019
Q2
Sell
-17,124
Closed -$4.91M 109
2019
Q1
$4.91M Buy
17,124
+1,523
+10% +$440K 0.13% 77
2018
Q4
$4.1M Buy
15,601
+7,085
+83% +$1.95M 0.18% 68
2018
Q3
$2.33M Sell
8,516
-203
-2% -$52.7K 0.05% 106
2018
Q2
$2.08M Sell
8,719
-668
-7% -$155K 0.06% 104
2018
Q1
$2.06M Buy
+9,387
New +$2.21M 0.06% 99

Other funds holding ELV

Churchill Management's ELV Position: Q4 2024 in Review

Churchill Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,851 shares — an estimated $1.48M sold.

Churchill Management first reported a position in ELV in Q1 2018 and held it in 15 quarters. The position peaked at $13.4M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Churchill Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Churchill Management sold 2,851 Elevance Health shares in Q4 2024, an estimated $1.48M.
  • Churchill Management first reported a position in Elevance Health in Q1 2018 and held it in 15 quarters.
  • Churchill Management's Elevance Health position peaked at $13.4M in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Churchill Management's 13F filing for Q4 2024, filed 14 Jan 2025.